Pancreatic Cancer and Osteopontin: The Relationship Remains Unclear

Pancreas

Volumn 45, Issue 7, 2016, Pages e35-e36

  Weber, Cynthia E ^a   Erşahin, Çaǧatay H ^a   Kuo, Paul C ^a   Mi, Zhiyong ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MICROARRAY ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; METABOLISM; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SECRETION (PROCESS); TISSUE MICROARRAY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOPONTIN; PANCREAS; PANCREATIC NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84979562086     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000639     Document Type: Letter

References (7)

1. Cancer Society Facts and Figures 2014. Available at: http://www.cancer.org/acs/groups/ content/@research/documents/webcontent/ acspc-042151.pdf. Accessed May 29, 2014.
2. Weber GF, Lett GS, Haubein NC. Categorical meta-analysis of osteopontin as a clinical cancer marker. Oncol Rep. 2010;25:433-441.
3. Bramwell VH, Doig GS, Tuck AB, et al. Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin Cancer Res. 2006;12:3337-3343.
4. Tilli TM, Thuler LC, Matos AR, et al. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Exp Mol Pathol. 2012;92:13-19.
5. Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer. 2003;98:119-127.
6. Koopmann J, Fedarko NS, Jain A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:487-491.
7. Nolen BM, Brand RE, Prosser D, et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. PLoS One. 2014; 9:e94928.